☰

G Frederick Wooten - Publications

Affiliations: 
Neurology University of Virginia School of Medicine, Charlottesville, VA, United States 
Tree Info Grants Similar researchers PubMed Report error

27 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Barrett MJ, Hac NE, Yan G, Harrison MB, Wooten GF. Relationship of age of onset and family history in Parkinson disease. Movement Disorders : Official Journal of the Movement Disorder Society. 30: 733-5. PMID 25737058 DOI: 10.1002/mds.26166  0.303
2014 Morgan JC, Currie LJ, Harrison MB, Bennett JP, Trugman JM, Wooten GF. Mortality in levodopa-treated Parkinson's disease. Parkinson's Disease. 2014: 426976. PMID 24616821 DOI: 10.1155/2014/426976  0.391
2011 Claassen DO, van den Wildenberg WP, Ridderinkhof KR, Jessup CK, Harrison MB, Wooten GF, Wylie SA. The risky business of dopamine agonists in Parkinson disease and impulse control disorders. Behavioral Neuroscience. 125: 492-500. PMID 21604834 DOI: 10.1037/A0023795  0.355
2009 Harrison MB, Wylie SA, Frysinger RC, Patrie JT, Huss DS, Currie LJ, Wooten GF. UPDRS activity of daily living score as a marker of Parkinson's disease progression. Movement Disorders : Official Journal of the Movement Disorder Society. 24: 224-30. PMID 18951537 DOI: 10.1002/Mds.22335  0.359
2008 Latourelle JC, Sun M, Lew MF, Suchowersky O, Klein C, Golbe LI, Mark MH, Growdon JH, Wooten GF, Watts RL, Guttman M, Racette BA, Perlmutter JS, Ahmed A, Shill HA, et al. The Gly2019Ser mutation in LRRK2 is not fully penetrant in familial Parkinson's disease: the GenePD study. Bmc Medicine. 6: 32. PMID 18986508 DOI: 10.1186/1741-7015-6-32  0.559
2008 McNicoll CF, Latourelle JC, MacDonald ME, Lew MF, Suchowersky O, Klein C, Golbe LI, Mark MH, Growdon JH, Wooten GF, Watts RL, Guttman M, Racette BA, Perlmutter JS, Ahmed A, et al. Huntington CAG repeat size does not modify onset age in familial Parkinson's disease: the GenePD study. Movement Disorders : Official Journal of the Movement Disorder Society. 23: 1596-601. PMID 18649400 DOI: 10.1002/Mds.22186  0.568
2008 DeStefano AL, Latourelle J, Lew MF, Suchowersky O, Klein C, Golbe LI, Mark MH, Growdon JH, Wooten GF, Watts R, Guttman M, Racette BA, Perlmutter JS, Marlor L, Shill HA, et al. Replication of association between ELAVL4 and Parkinson disease: the GenePD study. Human Genetics. 124: 95-9. PMID 18587682 DOI: 10.1007/S00439-008-0526-4  0.509
2008 Kieburtz K, Tilley B, Ravina B, Galpern W, Shannon K, Tanner C, Wooten GF. A pilot clinical trial of creatine and minocycline in early Parkinson disease: 18-Month results Clinical Neuropharmacology. 31: 141-150. PMID 18520981 DOI: 10.1097/Wnf.0B013E3181342F32  0.359
2008 Tobin JE, Latourelle JC, Lew MF, Klein C, Suchowersky O, Shill HA, Golbe LI, Mark MH, Growdon JH, Wooten GF, Racette BA, Perlmutter JS, Watts R, Guttman M, Baker KB, et al. Haplotypes and gene expression implicate the MAPT region for Parkinson disease: the GenePD Study. Neurology. 71: 28-34. PMID 18509094 DOI: 10.1212/01.Wnl.0000304051.01650.23  0.525
2007 Kieburtz K, Ravina B, Galpern WR, Tilley B, Shannon K, Tanner C, Wooten GF, Hamill R, Sage JI, Kosa E, Watts RL, Stover NR, McMurray R, Lew MF, Kawai C, et al. A randomized clinical trial of coenzyme Q10 and GPI-1485 in early Parkinson disease Neurology. 68: 20-28. PMID 17200487 DOI: 10.1212/01.Wnl.0000250355.28474.8E  0.337
2006 Wilk JB, Tobin JE, Suchowersky O, Shill HA, Klein C, Wooten GF, Lew MF, Mark MH, Guttman M, Watts RL, Singer C, Growdon JH, Latourelle JC, Saint-Hilaire MH, DeStefano AL, et al. Herbicide exposure modifies GSTP1 haplotype association to Parkinson onset age: the GenePD Study. Neurology. 67: 2206-10. PMID 17190945 DOI: 10.1212/01.Wnl.0000249149.22407.D1  0.496
2006 Sun M, Latourelle JC, Wooten GF, Lew MF, Klein C, Shill HA, Golbe LI, Mark MH, Racette BA, Perlmutter JS, Parsian A, Guttman M, Nicholson G, Xu G, Wilk JB, et al. Influence of heterozygosity for parkin mutation on onset age in familial Parkinson disease: the GenePD study. Archives of Neurology. 63: 826-32. PMID 16769863 DOI: 10.1001/Archneur.63.6.826  0.52
2005 Karamohamed S, Latourelle JC, Racette BA, Perlmutter JS, Wooten GF, Lew M, Klein C, Shill H, Golbe LI, Mark MH, Guttman M, Nicholson G, Wilk JB, Saint-Hilaire M, DeStefano AL, et al. BDNF genetic variants are associated with onset age of familial Parkinson disease: GenePD Study. Neurology. 65: 1823-5. PMID 16344533 DOI: 10.1212/01.Wnl.0000187075.81589.Fd  0.317
2005 Karamohamed S, Golbe LI, Mark MH, Lazzarini AM, Suchowersky O, Labelle N, Guttman M, Currie LJ, Wooten GF, Stacy M, Saint-Hilaire M, Feldman RG, Liu J, Shoemaker CM, Wilk JB, et al. Absence of previously reported variants in the SCNA (G88C and G209A), NR4A2 (T291D and T245G) and the DJ-1 (T497C) genes in familial Parkinson's disease from the GenePD study. Movement Disorders : Official Journal of the Movement Disorder Society. 20: 1188-91. PMID 15966003 DOI: 10.1002/Mds.20515  0.51
2004 Montgomery EB, Pan T, Le W, Jankovic J, Ahlskog JE, Wooten GF, Albin RL, Frey KA. Slowing Parkinson's disease progression: Recent dopamine agonist trials [3] (multiple letters) Neurology. 62: 343-345. DOI: 10.1212/Wnl.62.2.343  0.332
2003 Karamohamed S, DeStefano AL, Wilk JB, Shoemaker CM, Golbe LI, Mark MH, Lazzarini AM, Suchowersky O, Labelle N, Guttman M, Currie LJ, Wooten GF, Stacy M, Saint-Hilaire M, Feldman RG, et al. A haplotype at the PARK3 locus influences onset age for Parkinson's disease: the GenePD study. Neurology. 61: 1557-61. PMID 14663042 DOI: 10.1212/01.Wnl.0000095966.99430.F4  0.495
2002 DeStefano AL, Lew MF, Golbe LI, Mark MH, Lazzarini AM, Guttman M, Montgomery E, Waters CH, Singer C, Watts RL, Currie LJ, Wooten GF, Maher NE, Wilk JB, Sullivan KM, et al. PARK3 influences age at onset in Parkinson disease: a genome scan in the GenePD study. American Journal of Human Genetics. 70: 1089-95. PMID 11920285 DOI: 10.1086/339814  0.559
2002 Maher NE, Golbe LI, Lazzarini AM, Mark MH, Currie LJ, Wooten GF, Saint-Hilaire M, Wilk JB, Volcjak J, Maher JE, Feldman RG, Guttman M, Lew M, Waters CH, Schuman S, et al. Epidemiologic study of 203 sibling pairs with Parkinson's disease: the GenePD study. Neurology. 58: 79-84. PMID 11781409 DOI: 10.1212/Wnl.58.1.79  0.515
2001 DeStefano AL, Golbe LI, Mark MH, Lazzarini AM, Maher NE, Saint-Hilaire M, Feldman RG, Guttman M, Watts RL, Suchowersky O, Lafontaine AL, Labelle N, Lew MF, Waters CH, Growdon JH, ... ... Wooten GF, et al. Genome-wide scan for Parkinson's disease: the GenePD Study. Neurology. 57: 1124-6. PMID 11571351 DOI: 10.1212/Wnl.57.6.1124  0.488
1998 Swerdlow RH, Parks JK, Davis JN, Cassarino DS, Trimmer PA, Currie LJ, Dougherty J, Bridges WS, Bennett JP, Wooten GF, Parker WD. Matrilineal inheritance of complex I dysfunction in a multigenerational Parkinson's disease family. Annals of Neurology. 44: 873-81. PMID 9851431 DOI: 10.1002/Ana.410440605  0.341
1997 Wooten GF, Currie LJ, Bennett JP, Harrison MB, Trugman JM, Parker WD. Maternal inheritance in Parkinson's disease. Annals of Neurology. 41: 265-8. PMID 9029076 DOI: 10.1002/Ana.410410218  0.334
1987 Sanes DH, Geary WA, Wooten GF, Rubel EW. Quantitative distribution of the glycine receptor in the auditory brain stem of the gerbil. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 7: 3793-802. PMID 2890726 DOI: 10.1523/Jneurosci.07-11-03793.1987  0.595
1987 Sanes DH, Wooten GF. Development of glycine receptor distribution in the lateral superior olive of the gerbil. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 7: 3803-11. PMID 2824718 DOI: 10.1523/Jneurosci.07-11-03803.1987  0.534
1986 Trugman JM, Geary WA, Wooten GF. Localization of D-2 dopamine receptors to intrinsic striatal neurones by quantitative autoradiography. Nature. 323: 267-9. PMID 3762674 DOI: 10.1038/323267A0  0.334
1986 Bennett JP, Wooten GF. Dopamine denervation does not alter in vivo 3H-spiperone binding in rat striatum: implications for external imaging of dopamine receptors in Parkinson's disease. Annals of Neurology. 19: 378-83. PMID 3707090 DOI: 10.1002/Ana.410190412  0.322
1986 Trugman JM, Wooten GF. The effects of L-DOPA on regional cerebral glucose utilization in rats with unilateral lesions of the substantia nigra. Brain Research. 379: 264-74. PMID 3527339 DOI: 10.1016/0006-8993(86)90780-8  0.311
1982 Wooten GF, Horne MK. A new autoradiographic approach for imaging forebrain dopamine distribution. Annals of Neurology. 12: 163-8. PMID 6812487 DOI: 10.1002/Ana.410120206  0.305
Show low-probability matches.